Patent 12133919 was granted and assigned to Sol-Gel Technologies on November, 2024 by the United States Patent and Trademark Office.
The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.